Earnings GrowthThere is potential for the share to recover as focus shifts to the outlook and transition to year-over-year earnings growth in Q4, setting the stage for stronger 2025.
EBITDA Margin ImprovementEBITDA margin in Q3 is expected to strengthen due to improving sales volume and the absence of inventory variance as a headwind.
Valuation And Demand RecoveryThe analyst maintains a positive view on the shares, with a highly attractive valuation on depressed earnings and the strongest operating leverage to demand recovery in the coverage universe.